Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies
| CMALX Fund | USD 26.46 0.25 0.95% |
Slightly above 51% of Crawford Multi's investor base is interested to short. The analysis of overall sentiment of trading Crawford Multi Asset Income mutual fund suggests that many investors are impartial at this time. Crawford Multi's investing sentiment can be driven by a variety of factors including economic data, Crawford Multi's earnings reports, geopolitical events, and overall market trends.
Crawford |
New collaboration showcases successful integration of Oris IRO Platform with Cue and Lovo processing systems to enhance efficiency in CGT manufacturing Fresenius Kabi - Cue system Cue system Fresenius Kabi - Lovo with kit Lovo system with kit Ori Biotech IRO front IRO Ori Biotech open IRO Open IRO JCF with IRO Ori Biotech CEO Jason Foster with IRO technology LONDON and BAD HOMBURG, Germany, Dec. 10, 2024 -- Ori Biotech Ltd. , a leader in cell and gene therapy manufac
Read at finance.yahoo.com
 |
Crawford Multi Fundamental Analysis
We analyze Crawford Multi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Crawford Multi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Crawford Multi based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Crawford Multi is rated below average in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Crawford Multi Asset Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Crawford Multi mutual fund to make a market-neutral strategy. Peer analysis of Crawford Multi could also be used in its relative valuation, which is a method of valuing Crawford Multi by comparing valuation metrics with similar companies.
Peers
Crawford Multi Related Equities
| ADNPX | Amer Beacon | 1.92 | ||||
| MLPLX | Oppenheimer Steelpath | 1.90 | ||||
| LGLAX | Lord Abbett | 1.75 | ||||
| CMALX | Crawford Multi | 0.95 | ||||
| CDGIX | Crawford Dividend | 0.95 | ||||
| CDGCX | Crafword Dividend | 0.89 | ||||
| CDOFX | Crawford Dividend | 0.28 | ||||
| FLICX | Deutsche Munications | 0.10 | ||||
| NABEX | Neuberger Berman | 0.16 | ||||
| FFRIX | Fidelity Advisor | 0.22 |
Other Information on Investing in Crawford Mutual Fund
Crawford Multi financial ratios help investors to determine whether Crawford Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crawford with respect to the benefits of owning Crawford Multi security.
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |